S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Florida Cancer Specialists Expands Marion County Oncology Team

Florida Cancer Specialists & Research Institute has expanded its Marion County footprint, appointing hematologists and medical oncologists Sean Cohen, MD, and Ravi Koti, MD, to its clinical staff. The move aims to bolster access to specialized care across three distinct Ocala-area facilities as part of the practice's statewide growth.

Florida Cancer Specialists Expands Marion County Oncology Team
Photo: Bio & News

Dr. Cohen, a Florida Atlantic University medical graduate who completed his fellowship at Moffitt Cancer Center, now sees patients at the Ocala clinic on SE 18th Street and the Ocala Cancer Center on SW 49th Place. FCS assistant managing physician David Wenk noted that Cohen’s background in hematology and focus on patient communication are expected to enhance the group's community-based treatment capabilities.

Dr. Koti joins the practice at the Ocala Easy Street clinic. A graduate of Osmania Medical College with residency training at Brooklyn’s Coney Island Hospital, Koti holds board certifications in internal medicine, hematology, and medical oncology. CEO Ryan Ciarrocchi emphasized that Koti’s clinical experience and collaborative approach align with the organization's broader goal of providing individualized treatment options. The addition of both physicians reflects the institute's long-standing strategy of integrating advanced clinical research with localized, high-quality patient care.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!